The cost, and that is confidential & was negotiated for all in all , 300 million doses, is a little lower than the $19.50 a shot the United States agreed to purchase a first shipment of 100 million doses of the identical vaccine, in line with what Reuters claimed in November.
The EU booklet dated Nov. 18 was circulated internally following the EU announced the supply offer of its with Pfizer and the German partner BioNTech of its on Nov. eleven.
The EU drug regulator is actually expected to decide on Monday on endorsement for the Pfizer vaccine following the photo was authorised in a number of countries, including Britain and also the United States.
On Thursday Belgian say secretary on your budget Eva De Bleeker released on Twitter a dinner table with prices Belgium will spend pharmaceutical companies for their COVID 19 vaccines. She retracted the article shortly after publishing.
In this table the Pfizer vaccine was indicated as costing Belgium twelve euros ($14.6) per dose, top many to think this was the full cost agreed by the EU.
Other vaccines in the family table were also shown with prices lower compared to prices disclosed by EU solutions.
“There is , obviously , a complete price along with a cost upon delivery,” an EU official involved in talks with vaccine creators told Reuters when directed to clarify the big difference between the EU and Belgian rates.
A spokesman for De Bleeker declined to comment on Monday, citing confidentiality requirements, but pointed to what De Bleeker told the Belgian parliament previous week. In that public hearing, De Beeker said Belgium’s budgeted price tags were still partial.
Underneath EU advance purchase deals for COVID 19 vaccines, the bloc concurs initial payments with businesses to secure doses before they’re approved. Following approvals, EU governments can pay the remainder to get reserved doses.
The EU hasn’t revealed the initial transaction agreed with Pfizer.
However, it said in October which it paid aproximatelly one billion euros inside downpayments to AstraZeneca, Sanofi and Johnson and Johnson for the shots of theirs, with an additional 1.45 billion euros budgeted for upfront payments to Pfizer-BioNTech, Curevac and Moderna.
It’s since agreed supply deals with all 6 corporations and it is negotiating a seventh arrangement with Novavax.